Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Cancer Management and Research|May 23, 2019
Docetaxel, oxaliplatin, leucovorin, and 5-fluorouracil (FLOT) as preoperative and postoperative chemotherapy compared with surgery followed by chemotherapy for patients with locally advanced gastric cancer: a propensity score-based analysisKeshen Wang, Yanxian Ren, Zhijian Ma, et al.
Neoplasia (New York, N.Y.)|February 28, 2024
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populationsJing Hu, Xinyi Chen, Feifei Sun, et al.
Cell Communication and Signaling : CCS|June 19, 2024
Reciprocal regulation between RACGAP1 and AR contributes to endocrine therapy resistance in prostate cancerJiajia Wang, Hui Liu, Zeyuan Yu, et al.
Neoplasia (New York, N.Y.)|September 3, 2024
PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathwayJing Hu, Jing Zhang, Bo Han, et al.
Medical Oncology (Northwood, London, England)|November 20, 2024
Targeting the mevalonate pathway enhances the efficacy of 5-fluorouracil by regulating pyroptosisZongrui Xing, Yong Ma, Xiangyan Jiang, et al.
Nature Communications|May 15, 2021
Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancerWengui Shi, Gengyuan Zhang, Zhijian Ma, et al.
Gastroenterology|February 26, 2023
Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication StressXiangyan Jiang, Yong Ma, Tao Wang, et al.
Cancer Research|August 30, 2023
PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric CancerHuili Ye, Wengui Shi, Jing Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 15, 2026
UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition in Pancreatic CancerYong Ma, Wenbo Liu, Mingdou Li, et al.
Oncogene|December 16, 2020
A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitinationZeyuan Yu, Xiangyan Jiang, Long Qin, et al.
Pageof 6